An investigation into glioma patients reported a positive correlation between serum soluble α-Klotho (sαKlotho) levels and IL-6 (p = 0.0347), along with other biomarkers such as VEGF, fractalkine, IFN-γ, GDNF, IL-4, and IL-13. This evidence concerns the gene IL6 and central nervous system cancer.